These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21596564)

  • 21. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
    van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
    Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients.
    Lekanidi K; Evans AL; Shah J; Jaspan T; Baker L; Evans AJ
    Clin Radiol; 2013 Oct; 68(10):1070-3. PubMed ID: 23827085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of surgical treatment in breast cancer liver metastases: a single center experience.
    Bacalbasa N; Dima SO; Purtan-Purnichescu R; Herlea V; Popescu I
    Anticancer Res; 2014 Oct; 34(10):5563-8. PubMed ID: 25275056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis.
    Fennessy FM; Mortele KJ; Kluckert T; Gogate A; Ondategui-Parra S; Ros P; Silverman SG
    AJR Am J Roentgenol; 2004 Mar; 182(3):651-5. PubMed ID: 14975965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
    Chen J; Li Q; Wang C; Wu J; Zhao G
    Ann Surg Oncol; 2010 Jun; 17(6):1555-63. PubMed ID: 20069460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for liver metastases from breast cancer: results and prognostic factors.
    Li XP; Meng ZQ; Guo WJ; Li J
    World J Gastroenterol; 2005 Jun; 11(24):3782-7. PubMed ID: 15968739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
    Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
    Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases.
    Xu Z; Schlesinger D; Toulmin S; Rich T; Sheehan J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):612-8. PubMed ID: 22436795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
    Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
    J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
    Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
    J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distant metastases in ovarian carcinoma.
    Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
    Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of metastatic breast carcinoma: influence of tumour histological grade.
    Porter GJ; Evans AJ; Pinder SE; James JJ; Cornford EC; Burrell HC; Chan SY; Cheung KL; Robertson JF
    Clin Radiol; 2004 Dec; 59(12):1094-8. PubMed ID: 15556591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT staging for breast cancer patients with poor prognostic tumours.
    James JJ; McMahon MA; Tennant SL; Cornford EJ
    Breast; 2012 Dec; 21(6):735-8. PubMed ID: 22959310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for patients with hepatic metastases from breast cancer.
    Wyld L; Gutteridge E; Pinder SE; James JJ; Chan SY; Cheung KL; Robertson JF; Evans AJ
    Br J Cancer; 2003 Jul; 89(2):284-90. PubMed ID: 12865918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
    Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
    Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Fas (CD95) is a prognostic factor in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous stem cell transplantation.
    Bewick M; Conlon M; Parissenti AM; Lee H; Zhang L; Glück S; Lafrenie RM
    J Hematother Stem Cell Res; 2001 Dec; 10(6):759-68. PubMed ID: 11798502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.